Schedule 13G ownership disclosure
DelMar Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 247078108
Event date: 2017-04-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 461,536
- Percent of class
- 3.4300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000079
- Form type
- SC 13G
- Filer
- TuHURA Biosciences, Inc./NV
- CIK
- CIK 1498382
- Filed
- Apr 13, 2017
- Reporting period
- Apr 13, 2017
- Description
- Schedule 13G beneficial ownership